# Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines

> **NCT06559462** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 50 (actual)

## Conditions studied

- DPYD Gene Mutation
- Gastrointestinal Cancer
- Health Care Seeking Behavior

## Interventions

- **OTHER:** Focus Group
- **OTHER:** Discrete Choice

## Key facts

- **NCT ID:** NCT06559462
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-19
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-08-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06559462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06559462, "Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06559462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*